
Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffs
The Swiss drugmaker Roche has said it will put $50bn (£37bn) into manufacturing in the US over the next five years, joining the queue of companies unveiling investments to try to head off potentially punitive Donald Trump tariffs. Roche said on Tuesday the …